Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1997 1
2005 1
2006 1
2016 1
2018 2
2019 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean villa r (1,337 results)?
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.
Palumbo A, Chanan-Khan A, Weisel K, Nooka AK, Masszi T, Beksac M, Spicka I, Hungria V, Munder M, Mateos MV, Mark TM, Qi M, Schecter J, Amin H, Qin X, Deraedt W, Ahmadi T, Spencer A, Sonneveld P; CASTOR Investigators. Palumbo A, et al. N Engl J Med. 2016 Aug 25;375(8):754-66. doi: 10.1056/NEJMoa1606038. N Engl J Med. 2016. PMID: 27557302 Free article. Clinical Trial.
Hematopoietic stem cell transplantation (HSCT): an approach to autoimmunity.
Alaez C, Loyola M, Murguía A, Flores H, Rodríguez A, Ovilla R, Ignacio G, Amador R, Salinas V, Perez F, Rodríguez D, Morales Z, Llinguin G, Vazquez A, Altamirano A, Gorodezky C. Alaez C, et al. Among authors: ovilla r. Autoimmun Rev. 2006 Mar;5(3):167-79. doi: 10.1016/j.autrev.2005.06.003. Epub 2005 Jul 26. Autoimmun Rev. 2006. PMID: 16483916 Review.
Myelodysplastic syndromes in Latin America: state of the art.
Crisp R, Grille S, Belli C, Diaz L, Undurraga S, Navarro J, Vidal G, Gusmao B, Reyes J, Huaman F, Magalhaes S, Barroso F, Ovilla R, Flores G, Choque JA, Di Stefano M, Salinas V, Iastrebner M; Latin-American Group for Myelodysplastic Syndromes GLAM. Crisp R, et al. Among authors: ovilla r. Blood Adv. 2018 Nov 30;2(Suppl 1):60-62. doi: 10.1182/bloodadvances.2018GS110862. Blood Adv. 2018. PMID: 30504205 Free PMC article. No abstract available.
[Transfusion medicine].
Mejía-Arreguí M, Ovilla R, Girolami A, Ambriz-Fernández R. Mejía-Arreguí M, et al. Among authors: ovilla r. Rev Invest Clin. 1997 May;49 Suppl 1:64-74. Rev Invest Clin. 1997. PMID: 9380992 Review. Spanish. No abstract available.
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk.
Weisel K, Spencer A, Lentzsch S, Avet-Loiseau H, Mark TM, Spicka I, Masszi T, Lauri B, Levin MD, Bosi A, Hungria V, Cavo M, Lee JJ, Nooka A, Quach H, Munder M, Lee C, Barreto W, Corradini P, Min CK, Chanan-Khan AA, Horvath N, Capra M, Beksac M, Ovilla R, Jo JC, Shin HJ, Sonneveld P, Casneuf T, DeAngelis N, Amin H, Ukropec J, Kobos R, Mateos MV. Weisel K, et al. Among authors: ovilla r. J Hematol Oncol. 2020 Aug 20;13(1):115. doi: 10.1186/s13045-020-00948-5. J Hematol Oncol. 2020. PMID: 32819447 Free PMC article. Clinical Trial.
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Pavlovsky M, Cubero D, Agreda-Vásquez GP, Enrico A, Mela-Osorio MJ, San Sebastián JA, Fogliatto L, Ovilla R, Avendano O, Machnicki G, Barreyro P, Trufelli D, Villanova P. Pavlovsky M, et al. Among authors: ovilla r. JCO Glob Oncol. 2022 Mar;8:e2100265. doi: 10.1200/GO.21.00265. JCO Glob Oncol. 2022. PMID: 35486884 Free PMC article.
Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Tietsche de Moraes Hungria V, Chiattone C, Pavlovsky M, Abenoza LM, Agreda GP, Armenta J, Arrais C, Avendaño Flores O, Barroso F, Basquiera AL, Cao C, Cugliari MS, Enrico A, Foggliatto LM, Galvez KM, Gomez D, Gomez A, de Iracema D, Farias D, Lopez L, Mantilla WA, Martínez D, Mela MJ, Miguel CE, Ovilla R, Palmer L, Pavlovsky C, Ramos C, Remaggi G, Santucci R, Schusterschitz S, Sossa CL, Tuna-Aguilar E, Vela J, Santos T, de la Mora O, Machnicki G, Fernandez M, Barreyro P. Tietsche de Moraes Hungria V, et al. Among authors: ovilla r. J Glob Oncol. 2019 Nov;5:1-19. doi: 10.1200/JGO.19.00025. J Glob Oncol. 2019. PMID: 31774711 Free PMC article.
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR.
Spencer A, Lentzsch S, Weisel K, Avet-Loiseau H, Mark TM, Spicka I, Masszi T, Lauri B, Levin MD, Bosi A, Hungria V, Cavo M, Lee JJ, Nooka AK, Quach H, Lee C, Barreto W, Corradini P, Min CK, Scott EC, Chanan-Khan AA, Horvath N, Capra M, Beksac M, Ovilla R, Jo JC, Shin HJ, Sonneveld P, Soong D, Casneuf T, Chiu C, Amin H, Qi M, Thiyagarajah P, Sasser AK, Schecter JM, Mateos MV. Spencer A, et al. Among authors: ovilla r. Haematologica. 2018 Dec;103(12):2079-2087. doi: 10.3324/haematol.2018.194118. Epub 2018 Sep 20. Haematologica. 2018. PMID: 30237264 Free PMC article. Clinical Trial.